| | |
ASPsiRNA information |
siRNA Id: | aspsirna0543
|
siRNA Name: | SM2-RC(11)
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | AUUUCCGAGCGCGAAGAAG
|
ASP-siRNA (As strand 3'->5'): | AUUUCCGAACGCGAAGAAG
|
Mismatch position in siRNA: | A11G |
Gene Information |
Gene Name | Leucine rich repeat kinase 2 (LRRK2) |
Target Sequence (5'->3'): | CCTTGGCTCTTCAATATAAAGGCTCGCGCTTCTTCTTCCCCTG
|
Wild allele (5'->3'): | UAAAGGCUCGCGCUUCUUC
|
Mutant allele (5'->3'): | UAAAGGCUUGCGCUUCUUC
|
Position of siRNA on target gene: | 4434-4452
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_198578.3 |
Cytogenic location: | 12q12 |
Chromosomal coordinates: | 12:40,618,812-40,763,086 |
UniProt ID: | Q5S007 |
HUGO ID: | 18618 |
Reference SNp(RefSNP): | rs33939927 |
Disease/Mutation information |
Target Mutation: | c.4321C>T,p.Arg1441Cys
|
Matation type/variant: | Single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_011709.1:g.90424C>T
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Parkinsons disease (PD) |
Clinical Resources |
ClinVar ID: | 1938 |
KEGG disease ID: | H00057 |
OMIM ID: | 168600 |
COSMIC: | LRRK2 |
DECIPHER: | LRRK2 |
GeneTests: | LRRK2 |
ASP siRNA details |
Mutant allele (5'->3'): | UAAAGGCUUGCGCUUCUUC
|
ASP-siRNA (As strand 3'->5'): | AUUUCCGAACGCGAAGAAG
|
Percentage efficacy of ASP-siRNA for mutant allele: | 63
|
Wild allele (5'->3'): | UAAAGGCUCGCGCUUCUUC
|
ASP-siRNA (As strand 3'->5'): | AUUUCCGAACGCGAAGAAG
|
Percentage efficacy of ASP-siRNA for wild allele: | 75
|
Relative difference: | -12
|
Wild siRNA details |
Wild allele (5'->3'): | UAAAGGCUCGCGCUUCUUC
|
Wild siRNA (As strand 3'->5'): | AUUUCCGAGCGCGAAGAAG
|
Percentage efficacy of wild siRNA for wild allele: | NA
|
Wild allele (5'->3'): | UAAAGGCUCGCGCUUCUUC
|
ASP-siRNA (As strand 3'->5'): | AUUUCCGAACGCGAAGAAG
|
Percentage efficacy of Wild sirna for mutant allele: | NA
|
Relative difference : | NA
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA
|
Cell-line used: | 293T |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Arrest-In reagent |
siRNA expression method: | Open-Biosystems |
Post-transfection duration: | 48 hours |
Concentration used: | 400ng |
Reference: | 21712955 |
Delivery method: | Transfection |
Article title: | Efficient allele-specific targeting of LRRK2 R1441 mutations mediated by RNAi. |
Authors: | de Yñigo-Mojado L, Martín-Ruíz I, Sutherland JD. |
Journal Reference: | PLoS One. 2011;6(6):e21352. doi: 10.1371/journal.pone.0021352. Epub 2011 Jun 21. |